All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: HIV Infections-12657161
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 12657161 A62V
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
2 12657161 A71T
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
3 12657161 A71V
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
4 12657161 A98G
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
5 12657161 D67N
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
6 12657161 E44D
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
7 12657161 F116Y
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
8 12657161 F53L
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
9 12657161 F77L
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
10 12657161 G190A
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
11 12657161 G190S
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
12 12657161 G48V
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
13 12657161 H208Y
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
14 12657161 I54V
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
15 12657161 K101E
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
16 12657161 K103N
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
17 12657161 K20R
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
18 12657161 K219Q
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
19 12657161 K65R
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
20 12657161 K70R
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
21 12657161 L100I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
22 12657161 L10I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
23 12657161 L10V
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
24 12657161 L210W
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
25 12657161 L63P
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
26 12657161 L74V
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
27 12657161 L90M
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
28 12657161 M184I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
29 12657161 M184V
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
30 12657161 M36I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
31 12657161 M41L
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
32 12657161 M46I
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
33 12657161 Q151M
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
34 12657161 T215F
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
35 12657161 T215Y
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
36 12657161 T69D
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
37 12657161 V108I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
38 12657161 V118I
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
39 12657161 V179D
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
40 12657161 V75M
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
41 12657161 V75T
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
42 12657161 V82A
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
43 12657161 V82F
PR
gag-pol
HIV Infections
D
G
R
S
C
L
View
44 12657161 Y181C
RT
gag-pol
HIV Infections
D
G
R
S
C
L
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.